Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis

Gomez-Ospina, Natalia, Potter, Carol J., Xiao, Rui, Manickam, Kandamurugu, Kim, Mi-Sun, Kim, Kang Ho, Shneider, Benjamin L., Picarsic, Jennifer L. +21 more·2016·Nature Communications

Cited by (302)

Items 101–200 of 302

  1. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects
    Piter J. Bosma, Marius Wits, Ronald P.J. Oude Elferink · 2020 · International Journal of Molecular Sciences
  2. Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor
    Longying Jiang, Desheng Xiao, Yubin Li, Shuyan Dai, Lingzhi Qu, Xiaojuan Chen, Ming Guo, Hudie Wei, Yongheng Chen · 2020 · Biochemical and Biophysical Research Communications
  3. Bile acid homeostasis controls CAR signaling pathways in mouse testis through FXRalpha
    Emmanuelle Martinot, Marine Baptissart, Aurélie Vega, Lauriane Sèdes, Betty Rouaisnel, Frédéric Maxime Vaz, Jean‐Paul Saru, Angélique De Haze, Silvère Baron, Françoise Caira et al. · 2017 · Scientific Reports
  4. Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α
    Kang Ho Kim, David D. Moore · 2017 · Digestive Diseases
  5. Bile Acids and Biliary Fibrosis
    Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou · 2023 · Cells
  6. The zonula occludens protein family regulates the hepatic barrier system in the murine liver
    Masahiko Itoh, Misao Terada, Hiroyuki Sugimoto · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  7. Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms
    Duc-Hung Pham, Ramesh Kudira, Lingfen Xu, C. Alexander Valencia, Jillian L. Ellis, Tiffany Shi, Kimberley Jane Evason, Immaculeta Osuji, Nelson Matuschek, Liva Pfuhler et al. · 2021 · Gastroenterology
  8. Progressive familial intrahepatic cholestasis — farnesoid X receptor deficiency due to NR1H4 mutation: A case report
    Piotr Czubkowski, Richard J. Thompson, Irena Jankowska, Alex S. Knisely, Milton J. Finegold, Pamela Parsons, Joanna Cielecka–Kuszyk, Sandra S. Strautnieks, Joanna Pawłowska, Laura N. Bull · 2021 · World Journal of Clinical Cases
  9. Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations
    Teng Liu, Ren‐Xue Wang, Jun Han, Chenzhi Hao, Yi‐Ling Qiu, Yanyan Yan, Liting Li, Neng‐Li Wang, Jing‐Yu Gong, Yi Lu et al. · 2018 · Liver International
  10. Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease
    Ting Ge, Xinyue Zhang, Yongmei Xiao, Yizhong Wang, Ting Zhang · 2019 · BMC Medical Genetics
  11. Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management
    Saul J. Karpen · 2020 · Clinical Liver Disease
  12. Long-term outcomes of six patients after partial internal biliary diversion for progressive familial intrahepatic cholestasis
    Başak Erginel, Feryal Gül Soysal, Özlem Durmaz, Alaattin Celik, Tansu Salman · 2017 · Journal of Pediatric Surgery
  13. FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression
    Sai Wang, Rilu Feng, Shanshan Wang, Hui Liu, Chen Shao, Yujia Li, Frederik Link, Stefan Munker, Roman Liebe, Christoph Meyer et al. · 2022 · Gut
  14. Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function
    Chang Yeob Han, Tae Hyun Kim, Ja Hyun Koo, Sang Geon Kim · 2016 · Archives of Pharmacal Research
  15. Grape Seed Proanthocyanidin Alleviates Intestinal Inflammation Through Gut Microbiota-Bile Acid Crosstalk in Mice
    Yi Wu, Ruixia Mo, Mingrui Zhang, Weiwei Zhou, Defa Li · 2022 · Frontiers in Nutrition
  16. Bile Acids—A Peek Into Their History and Signaling
    James ThienToan Nguyen, Ryan Philip Henry Shaw, Sayeepriyadarshini Anakk · 2022 · Endocrinology
  17. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism
    Marica Cariello, Marilidia Piglionica, Raffaella Maria Gadaleta, Antonio Moschetta · 2019 · Handbook of experimental pharmacology
  18. Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury
    Li Ren, Qing Song, Yunhuan Liu, Lihua Zhang, Zhiming Hao, Wenke Feng · 2019 · Biochemical and Biophysical Research Communications
  19. Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
    Longying Jiang, Xueke Liu, Xujun Liang, Shuyan Dai, Hudie Wei, Ming Guo, Zhuchu Chen, Desheng Xiao, Yongheng Chen · 2023 · Computational and Structural Biotechnology Journal
  20. Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: Role of FXR and Nrf2 pathways
    Peng Cao, Jun Gan, Sanlan Wu, Yixin Hu, Bin Xia, Xiaoyue Li, Hongan Zeng, Bingyu Cheng, Huifan Yu, Fei Li et al. · 2023 · Food and Chemical Toxicology
  21. The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.
    Yun Jeong Lee, Eun‐Young Lee, Bo Hee Choi, Hyonchol Jang, Jae‐Kyung Myung, Hye Jin You · 2020 · PubMed Central
  22. Nuclear receptors and liver disease: summary of the 2017 basic research symposium
    Tran, Melanie, Liu, Yanjun, Huang, Wendong, Wang, Li · 2018 · Hepatology Communications
  23. Biallelic Mutations in the LSR Gene Cause a Novel Type of Infantile Intrahepatic Cholestasis
    Tomoko Uehara, Mamiko Yamada, Shuichiro Umetsu, Hiroshi Nittono, Hisato Suzuki, Tomoo Fujisawa, Toshiki Takenouchi, Ayano Inui, Kenjiro Kosaki · 2020 · The Journal of Pediatrics
  24. Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases
    Chen Chi-bo, Jacob Shujui Hsu, Pei‐Lung Chen, Jia‐Feng Wu, Huei-Ying Li, Bang‐Yu Liou, Mei‐Hwei Chang, Yen‐Hsuan Ni, Wuh‐Liang Hwu, Yin‐Hsiu Chien et al. · 2023 · The Journal of Pediatrics
  25. Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination
    Luise Aamann, Nikolaj Worm Ørntoft, Ida Vogel, Henning Grønbæk, Naja Becher, Hendrik Vilstrup, Peter Ott, Dorte Launholt Lildballe · 2018 · Scandinavian Journal of Gastroenterology
  26. A Link between Intrahepatic Cholestasis and Genetic Variations in Intracellular Trafficking Regulators
    Qinghong Li, Yue Sun, Sven C.D. van IJzendoorn · 2021 · Biology
  27. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease
    Bruno Stieger, Zaynab Mahdi · 2017 · Journal of Pharmaceutical Sciences
  28. Paediatric research sets new standards for therapy in paediatric and adult cholestasis
    Rebecca Jeyaraj, Eamonn Richard Maher, Deirdre Anne Kelly · 2023 · The Lancet Child & Adolescent Health
  29. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials
    Willemien F. J. Hof, Jan Freark de Boer, Henkjan J. Verkade · 2024 · Expert Opinion on Emerging Drugs
  30. Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
    Shuying Xie, Shizhang Wei, Xiao Ma, Ruilin Wang, Tingting He, Zhao Zhang, Ju Yang, Jiawei Wang, Lei Chang, Manyi Jing et al. · 2023 · Frontiers in Pharmacology
  31. Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis
    Anna Maria Kavallar, Christoph Mayerhofer, Denise Aldrian, Tatsuya Okamoto, Thomas Müller, Georg Friedrich Vogel · 2023 · Hepatology Communications
  32. Contemporary Evaluation of the Pediatric Liver Biopsy
    Deborah A. Schady, Milton J. Finegold · 2017 · Gastroenterology Clinics of North America
  33. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis
    Kang Ho Kim, Jong Min Choi, Feng Li, Armando Arizpe, Clavia Ruth Wooton‐Kee, Sayeepriyadarshini Anakk, Sung Yun Jung, Milton J. Finegold, David D. Moore · 2018 · Endocrinology
  34. Molecular Mechanisms in Pediatric Cholestasis
    James E. Squires, Patrick James McKiernan · 2018 · Gastroenterology Clinics of North America
  35. Molecular findings in children with inherited intrahepatic cholestasis
    Neng‐Li Wang, Yi Lu, Jing‐Yu Gong, Xin‐Bao Xie, Jing Lin, Kuerbanjiang Abuduxikuer, Meihong Zhang, Jian‐She Wang · 2019 · Pediatric Research
  36. Liver transplantation in an infant with cerebrotendinous xanthomatosis, cholestasis, and rapid evolution of liver failure
    Andrea Pietrobattista, Marco Spada, Manila Candusso, Sara Boenzi, Carlo Dionisi‐Vici, Paola Francalanci, Amelia Morrone, Lorenzo Ferri, Giuseppe Indolfi, Emanuele Agolini et al. · 2022 · Pediatric Transplantation
  37. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches
    Michele Pinon, Binita Maya Kamath · 2024 · Current Opinion in Pediatrics
  38. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis
    Kazuo Imagawa, Hisamitsu Hayashi, Yusuke Sabu, Ken Tanikawa, Jun Fujishiro, Daigo Kajikawa, Hiroki Wada, Toyoichiro Kudo, Masayoshi Kage, Hiroyuki Kusuhara et al. · 2018 · Journal of Human Genetics
  39. Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis
    Mathur, Bhoomika, Arif, Waqar, Patton, Megan E., Faiyaz, Rahiman, Liu, Jian, Yeh, Jennifer, Harpavat, Sanjiv, Schoonjans, Kristina, Kalsotra, Auinash, Wheatley, Antony M. et al. · 2020 · JHEP Reports
  40. Eggerthella lenta DSM 2243 Alleviates Bile Acid Stress Response in Clostridium ramosum and Anaerostipes caccae by Transformation of Bile Acids
    Kristian Jensen Pedersen, Sven‐Bastiaan Haange, Kateřina Žížalová, Alina Viehof, Thomas Clavel, Martin Leníček, Beatrice Engelmann, Lukas Y. Wick, Frank G. Schaap, Nico Jehmlich et al. · 2022 · Microorganisms
  41. Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
    Aze Suzanne Wilson, Qian Wang, Ahmed A. Almousa, Laura E. Jansen, Yun‐Hee Choi, Ute I. Schwarz, Richard B. Kim · 2020 · Scientific Reports
  42. Bile Acid-Induced Liver Injury in Cholestasis
    Tiangang Li, John Y.L. Chiang · 2017 · Springer eBooks
  43. Regulation of Chromatin Accessibility by the Farnesoid X Receptor Is Essential for Circadian and Bile Acid Homeostasis In Vivo
    Haider M. Hassan, Oladapo Onabote, Majdina Isovic, Daniel T. Passos, Frederick A. Dick, Joseph Torchia · 2022 · Cancers
  44. Gene Therapy for Acquired and Genetic Cholestasis
    Javier Martínez-García, Angie Molina, Gloria González‐Aseguinolaza, Nicholas D. Weber, Cristian Smerdou · 2022 · Biomedicines
  45. Treatment of Cholestasis in Infants and Young Children
    Nicole Heinz, Jennifer Vittorio · 2023 · Current Gastroenterology Reports
  46. Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis
    Satoshi Nakano, Shuhei Osaka, Yusuke Sabu, Kei Minowa, Saeko Hirai, Hiroki Kondou, Takeshi Kimura, Yoshihiro Azuma, Satoshi Watanabe, Ayano Inui et al. · 2019 · Scientific Reports
  47. NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings
    Fengfeng Mao, Mengxuan Wang, Xinfeng Hou, Zhongmin Zhou, Yanyan Yan, Ling‐Juan Fang, Zexi Tan, Weiyuan Fang, Teng Liu, Wenhui He et al. · 2020 · Cellular and Molecular Gastroenterology and Hepatology
  48. Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury
    Xingjuan Gao, Jiaju Xu, Hongbo Liu · 2020 · Molecular Medicine Reports
  49. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers
    Ming‐Shian Tsai, Hui-Ming Lee, Shih-Che Huang, Cheuk‐Kwan Sun, Ting-Chia Chiu, Po‐Han Chen, Yu‐Chun Lin, Tzu‐Min Hung, Po‐Huang Lee, Y. H. Kao · 2020 · Archives of Biochemistry and Biophysics
  50. Farnesoid X receptor alpha (FXRα) is a critical actor of the development and pathologies of the male reproductive system
    Manon Garcia, Laura Thirouard, Mélusine Monrose, Hélène Holota, Angélique De Haze, Françoise Caira, Claude Beaudoin, David H. Volle · 2019 · Cellular and Molecular Life Sciences
  51. Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India
    Sagar Mehta, Karunesh Kumar, Ravi Bhardwaj, Smita Malhotra, Neerav Goyal, Anupam Sibal · 2021 · Journal of Clinical and Experimental Hepatology
  52. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report
    Jie Bai, Lu Li, Hui Liu, Shuang Liu, Li Bai, Hanbing Ning, Wenyan Song, Huaibin Zou, Xinxin Wang, Yu Chen et al. · 2021 · Annals of Translational Medicine
  53. Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond
    Ruizhi Gu, Alina Liang, Grace Liao, Isabelle To, Amina I. Shehu, Xiaochao Ma · 2022 · Drug Metabolism and Disposition
  54. Drug-induced liver injury: An overview and update
    Yujie Wang, Wen Xie · 2023 · Gastroenterology & Endoscopy
  55. iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis
    Malte Sgodda, Evelyn Gebel, Lennart Dignas, Susanne Alfken, Reto Eggenschwiler, Amelie Stalke, Carola Dröge, Eva‐Doreen Pfister, Ulrich Baumann, Tom Luedde et al. · 2025 · Hepatology Communications
  56. Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor
    Longying Jiang, Xueke Liu, Hudie Wei, Shuyan Dai, Lingzhi Qu, Xiaojuan Chen, Ming Guo, Yongheng Chen · 2022 · Biochemical and Biophysical Research Communications
  57. Cholestasis After Pediatric Liver Transplantation–Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report
    Benas Prušinskas, Simone Kathemann, Denisa Pilic, Bianca Hegen, Peter Küster, Verena Keitel, Dieter Häussinger, Rainer Büscher, Hideo Andreas Baba, Peter F. Hoyer et al. · 2017 · Transplantation Proceedings
  58. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications
    Sze Pheh Yeap, H. Harley, Richard J. Thompson, Kate D. Williamson, John P. Bate, Farah Sethna, Geoffrey C. Farrell, William M. Hague · 2018 · Journal of Gastroenterology and Hepatology
  59. Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta‐Analysis
    Yuan Gao, Li Li, Bei Li, Yutao Zhan · 2021 · Canadian Journal of Gastroenterology and Hepatology
  60. A rare missense variant in NR1H4 associates with lower cholesterol levels
    Aimée M. Deaton, Patrick Sulem, Paul Nioi, Stefania Benónísdóttir, Lucas D. Ward, Olafur B. Davidsson, Socheata Lao, Anna Helgadóttir, Fan Fan, Brynjar Ö. Jensson et al. · 2018 · Communications Biology
  61. Long‐term outcomes after cholecystocolostomy for progressive familial intrahepatic cholestasis
    Long Chen, Hui Xiao, Xianghai Ren, Long Li · 2018 · Hepatology Research
  62. Diagnostic algorithm for neonatal intrahepatic cholestasis integrating single‐gene testing and next‐generation sequencing in East Asia
    Jong Woo Hahn, Heerah Lee, Minsoo Shin, Moon‐Woo Seong, Jin Soo Moon, Jae Sung Ko · 2024 · Journal of Gastroenterology and Hepatology
  63. Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient‐Sensing Nuclear Receptors
    Geoffrey A. Preidis, Krishnakant G. Soni, Ji Ho Suh, Tripti Halder, Kang Ho Kim, Jong Min Choi, Feng Li, Sridevi Devaraj, Margaret E. Conner, Cristian Coarfa et al. · 2020 · Hepatology Communications
  64. Cholestasis in the Premature Infant
    Carol Potter · 2020 · Clinics in Perinatology
  65. Bilirubin Metabolism and Jaundice
    Allan W. Wolkoff, Paul D. Berk · 2017
  66. Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease
    Magdaléna Neřoldová, Elżbieta Ciara, Janka Slatinská, Soňa Fraňková, Petra Lišková, Radana Kotalová, Janka Globinovská, Markéta Šafaříková, Lucie Pfeiferová, Hana Zůnová et al. · 2023 · PLoS ONE
  67. Neonatal liver disease
    Helen Evans, Susan Siew · 2020 · Journal of Paediatrics and Child Health
  68. Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis
    Sarah M. Bedoyan, Olya T. Lovell, Simon Peter Horslen, James E. Squires · 2022 · Expert Opinion on Pharmacotherapy
  69. Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice
    Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira F. Gohara, Ramakumar Tummala, Stanislaw M. Stepkowski, Amit Kumar Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz et al. · 2023 · Hepatology Communications
  70. Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1
    Zhenxiu Liu, Lin Chen, Mingyun Chen, Lang Linghu, Zhihua Liao, Min Chen, Guowei Wang · 2024 · Phytomedicine
  71. Assessment of Adenosine Triphosphatase Phospholipid Transporting 8B1 (ATP8B1) Function in Patients With Cholestasis With ATP8B1 Deficiency by Using Peripheral Blood Monocyte-Derived Macrophages
    Ayumu Mizutani, Yusuke Sabu, Sotaro Naoi, Shogo Ito, Satoshi Nakano, Kei Minowa, Tatsuki Mizuochi, Koichi Ito, Daiki Abukawa, Shunsaku Kaji et al. · 2020 · Hepatology Communications
  72. Hepatic Deletion of X-Box Binding Protein 1 in FXR Null Mice Leads to Enhanced Liver Injury
    Xiaoying Liu, Mahmoud G. Khalafalla, Chuhan Chung, Yevgeniy Gindin, Susan C. Hubchak, Brian E. LeCuyer, Alyssa A. Kriegermeier, Danny Zhang, Wei Qiu, Xianzhong Ding et al. · 2022 · Journal of Lipid Research
  73. Increased serum delta neutrophil index levels are associated with intrahepatic cholestasis of pregnancy
    Hasan Eroğlu, Nihal Şahin Uysal, Kemal Sarsmaz, Nazan Vanlı Tonyalı, Bahadır Codal, Aykan Yücel · 2021 · Journal of obstetrics and gynaecology research
  74. Robust fine-mapping in the presence of linkage disequilibrium mismatch
    Wenmin Zhang, Tianyuan Lu, ROBERT M. SLADEK, Josée Dupuis, Guillaume Lettre · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Transcriptional Control of Trpm6 by the Nuclear Receptor FXR
    Eun Young Kim, Jae Man Lee · 2022 · International Journal of Molecular Sciences
  76. Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study
    Leonardo Ruiz‐Casas, Sonia O’Hara, Claudia Mighiu, Alan Paul Finnegan, Alison H. M. Taylor, Emily E. Ventura, Anil Kumar Dhawan, Karen F. Murray, Jörn Markus Schattenberg, José Willemse et al. · 2021 · Expert Review of Pharmacoeconomics & Outcomes Research
  77. An overview of recent treatment options for primary sclerosing cholangitis
    Ioanna Mousavere · 2023 · Annals of Gastroenterology
  78. NR1H4 disease: rapidly progressing neonatal intrahepatic cholestasis and early death
    Zhong‐Die Li, Yu‐Chuan Li, Jing-Zhao, Jian‐She Wang, Xin‐Bao Xie · 2024 · Orphanet Journal of Rare Diseases
  79. A Diagnostic Quagmire: PFIC5 Presenting as a Rare Cause of Neonatal Cholestasis
    Sophia Giang, Ruth Lillian Gordon, Kelly Haas · 2021 · ACG Case Reports Journal
  80. Bile Acids as Signaling Molecules
    Thierry Claudel, Michael A Trauner · 2020 · Liver
  81. Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
    Megan E Patton, Sherwin Kelekar, Lauren J. Taylor, Angela Elizabeth Dean, Qianying Zuo, Rhishikesh N. Thakare, Sung Hwan Lee, Emily C. Gentry, Morgan W. Panitchpakdi, Pieter C. Dorrestein et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy
    Eun Young Kim, Jae Man Lee · 2025 · International Journal of Molecular Sciences
  83. Challenges in the diagnosis and treatment of genetic cholestasis in adults
    Richard J. Thompson, Sílvia Vilarinho, Rosa Miquel, Verena Keitel · 2025 · JHEP Reports
  84. Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance
    Qiang Chen, Xin LIU, Zi-Hao Jiang · 2026 · Hepatobiliary & pancreatic diseases international
  85. Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis
    Teng Liu, Renxue Wang, Jun Young Han, Zhong‐Die Li, Jonathan A. Sheps, Lijuan Zheng, Xiaoxiao Xu, Victor Wei Teik Ling, Jian‐She Wang · 2023 · Journal of Clinical and Translational Hepatology
  86. NR1H4 mutation and rapid progressive intrahepatic cholestasis in infancy: A case report and literature review
    Chiao‐Yu Yang, Hung‐Wen Tsai, Yen‐Yin Chou, Yao‐Jong Yang · 2024 · Clinical Case Reports
  87. Genetic Disorders of Bile Acid Transport
    Anne S. Henkel · 2021 · Clinical Liver Disease
  88. Identification of two novel pathogenic variants of the NR1H4 gene in intrahepatic cholestasis of pregnancy patients
    Hua Lai, Xianxian Liu, Siming Xin, Jiusheng Zheng, Huai Liu, Yu Ouyang, Huoxiu Yang, Yang Zeng, Yang Zou, Xiaoming Zeng · 2022 · BMC Medical Genomics
  89. Nuclear receptors as pharmacological targets, where are we now?
    David H. Volle · 2016 · Cellular and Molecular Life Sciences
  90. Developmental and Inherited Liver Disease
    Alberto Quaglia, Eve A. Roberts, Michael S Torbenson · 2023 · Elsevier eBooks
  91. Gly-β-MCA is a potent anti-cholestasis agent against “human-like” hydrophobic bile acid-induced biliary injury in mice
    Mohammad Nazmul Hasan, Huaiwen Wang, Wenyi Luo, Yung Dai Clayton, Lijie Gu, Yanhong Du, Sirish Kumar Palle, Jianglei Chen, Tiangang Li · 2024 · Journal of Lipid Research
  92. Immunohistochemistry in Progressive Familial Intrahepatic Cholestasis (PFIC): Bridging Gap Between Morphology and Genetics
    Neha Nigam, Chhagan Bihari, Moinak Sen Sarma, Anshu Srivastava, Narendra Krishnani, Prabhakar Mishra · 2025 · Journal of Clinical and Experimental Hepatology
  93. A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis
    Annika Behrendt, Alex Bastianelli, Jan Stindt, Eva‐Doreen Pfister, Malte Sgodda, Tobias Cantz, Sebastian Hook, Mohanraj Gopalswamy, Kathrin Grau, Stefanie Brands et al. · 2025 · Journal of Biological Chemistry
  94. Pathology of Progressive Familial Intrahepatic Cholestasis: An update
    Suvradeep Mitra, Mukul Vij, Jagadeesh Menon, Naresh P Shanmugam, Mohamed Rela · 2026 · Pediatric and Developmental Pathology
  95. Atypical Hepatic Mesenchymal Hamartoma: Histologic Appearance, Immunophenotype, and Molecular Findings
    Dina El Demellawy, James Y J Lee, Laura M. McDonell, David Alexandre Dyment, Alexander S. Knisely, Jean McGowan‐Jordan, BY Ngan, Milton J. Finegold, Raj P. Kapur, Ahmed Nasr · 2018 · Pediatric and Developmental Pathology
  96. Novel mutation of the TJP2 gene in a Chinese child with progressive cholestatic liver disease coexistent with hearing impairment
    Jing Zhang, Shu Guo, Tian-Lu Mei, Jin Zhou, Dexiu Guan, Guoli Wang · 2020 · Hepatobiliary & pancreatic diseases international
  97. Dialogs in the assessment of neonatal cholestatic liver disease
    Soo‐Jin Cho, Emily Rothbaum Perito, Nafis Shafizadeh, Grace Kim · 2021 · Human Pathology
  98. Iberogast®-Induced Acute Liver Injury—A Case Report
    Alice Leroy, Henri Perrin, Raphaël Porret, Christine L Sempoux, Haïthem Chtioui, Montserrat Christinet Fraga, Pierre‐Alexandre Bart · 2022 · Gastro Hep Advances
  99. Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
    Rulin Wang, Tengteng Yuan, Jing Sun, Menghuan Yang, Yunna Chen, Lei Wang, Yanyan Wang, Weidong Chen, Daiyin Peng · 2022 · Frontiers in Pharmacology
  100. Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
    Lili Xi, Axi Shi, Tiantian Shen, Guoxu Wang, Yuhui Wei, Jingjing Guo · 2023 · Frontiers in Pharmacology